Amgen Inc.
Pharmaceutical composition comprising bispecific antibody constructs
Last updated:
Abstract:
The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.
Status:
Grant
Type:
Utility
Filling date:
25 Jan 2017
Issue date:
23 Aug 2022